31 Oct 2019

 RA MEDICAL SYSTEMS DETAILS SUBSTANTIAL COMPLETION OF AUDIT COMMITTEE INVESTIGATION

  Ra Medical Systems Inc., a medical device company focusing on commercializing excimer laser systems to treat vascular and dermatological diseases, announced Oct. 31 that the Audit Committee of the Board of Directors has substantially completed its internal investigation, announced in August. The Audit Committee, assisted by independent legal counsel,

0
13 Apr 2019

DABRA hits 94% success rate in treating PAD

Ra Medical Systems Inc. announced in early March study results that concluded DABRA Laser System achieved 94 percent success rates in patients with peripheral artery disease. Athar Ansari, MD, director of the California Heart & Vascular Clinic and principal in the study, said DABRA (Destruction of Arteriosclerotic Blockages by laser

0
11 Dec 2018

RA MED SYSTEMS NEAR COMPLETION OF IPO OFFERING

  Ra Medical Systems has filed an amended S-1 form with the U.S. Securities and Exchange Commission (SEC) for its initial public offering. No pricing details were given in the filing, but the offering is valued up to $86.25 million. The company intends to list its shares on the New

0